| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
|
LeWitt, Peter A
|
|
2011
|
10 |
4 |
p. 309-319
11 p.
|
artikel
|
| 2 |
A bridge from bedside to clinical electrophysiology?
|
Laufs, Helmut
|
|
2011
|
10 |
4 |
p. 306-
1 p.
|
artikel
|
| 3 |
Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes
|
Coles, Alasdair J
|
|
2011
|
10 |
4 |
p. 338-348
11 p.
|
artikel
|
| 4 |
Ascorbic acid for treatment in CMT1A: what's next?
|
de Visser, Marianne
|
|
2011
|
10 |
4 |
p. 291-293
3 p.
|
artikel
|
| 5 |
Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial
|
Pareyson, Davide
|
|
2011
|
10 |
4 |
p. 320-328
9 p.
|
artikel
|
| 6 |
At last, a gene therapy for Parkinson's disease?
|
Hutchinson, Michael
|
|
2011
|
10 |
4 |
p. 290-291
2 p.
|
artikel
|
| 7 |
Changing concepts in Parkinson's disease
|
Jellinger, Kurt A
|
|
2011
|
10 |
4 |
p. 307-
1 p.
|
artikel
|
| 8 |
Clive Svendsen
|
|
|
2011
|
10 |
4 |
p. 305-
1 p.
|
artikel
|
| 9 |
Errata
|
|
|
2011
|
10 |
4 |
p. 297-
1 p.
|
artikel
|
| 10 |
Errata
|
|
|
2011
|
10 |
4 |
p. 297-
1 p.
|
artikel
|
| 11 |
Errata
|
|
|
2011
|
10 |
4 |
p. 297-
1 p.
|
artikel
|
| 12 |
Errata
|
|
|
2011
|
10 |
4 |
p. 297-
1 p.
|
artikel
|
| 13 |
Evolution of multiple sclerosis treatment: next generation therapies meet next generation efficacy criteria
|
Hartung, Hans-Peter
|
|
2011
|
10 |
4 |
p. 293-295
3 p.
|
artikel
|
| 14 |
Induced pluripotent stem cells: a new revolution for clinical neurology?
|
Mattis, Virginia B
|
|
2011
|
10 |
4 |
p. 383-394
12 p.
|
artikel
|
| 15 |
Is reduction of blood pressure in acute stroke justified?
|
Gorelick, Philip B
|
|
2011
|
10 |
4 |
p. 295-296
2 p.
|
artikel
|
| 16 |
January, 2011
|
|
|
2011
|
10 |
4 |
p. 305-
1 p.
|
artikel
|
| 17 |
Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage
|
Rinkel, Gabriel JE
|
|
2011
|
10 |
4 |
p. 349-356
8 p.
|
artikel
|
| 18 |
Multiple sclerosis—a call for papers
|
Brown, Heather
|
|
2011
|
10 |
4 |
p. 297-
1 p.
|
artikel
|
| 19 |
Neurological complications of acute ischaemic stroke
|
Balami, Joyce S
|
|
2011
|
10 |
4 |
p. 357-371
15 p.
|
artikel
|
| 20 |
Neurologists weigh in on sports-related concussions
|
Nierengarten, Mary Beth
|
|
2011
|
10 |
4 |
p. 302-303
2 p.
|
artikel
|
| 21 |
New lexicon and criteria for the diagnosis of Alzheimer's disease
|
Giaccone, Giorgio
|
|
2011
|
10 |
4 |
p. 298-299
2 p.
|
artikel
|
| 22 |
New lexicon and criteria for the diagnosis of Alzheimer's disease
|
Sohrabi, Hamid R
|
|
2011
|
10 |
4 |
p. 299-300
2 p.
|
artikel
|
| 23 |
New lexicon and criteria for the diagnosis of Alzheimer's disease – Authors' reply
|
Feldman, Howard H
|
|
2011
|
10 |
4 |
p. 300-301
2 p.
|
artikel
|
| 24 |
News in brief
|
|
|
2011
|
10 |
4 |
p. 308-
1 p.
|
artikel
|
| 25 |
Simon Shorvon: shining the spotlight on epilepsy
|
Kirby, Tony
|
|
2011
|
10 |
4 |
p. 304-
1 p.
|
artikel
|
| 26 |
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis
|
Giovannoni, Gavin
|
|
2011
|
10 |
4 |
p. 329-337
9 p.
|
artikel
|
| 27 |
Transcultural perspectives of dementia
|
Caixeta, Leonardo
|
|
2011
|
10 |
4 |
p. 306-307
2 p.
|
artikel
|
| 28 |
Treatment advances in neonatal neuroprotection and neurointensive care
|
Johnston, Michael V
|
|
2011
|
10 |
4 |
p. 372-382
11 p.
|
artikel
|
| 29 |
Why patients with aSAH need multidisciplinary follow-up
|
The Lancet Neurology,
|
|
2011
|
10 |
4 |
p. 289-
1 p.
|
artikel
|
Tijdschrift beschrijving